Hongri Pharmaceutical: Net profit of 184.951 million yuan in 2025, down 13.85% year-on-year

Hongri Pharmaceutical announces that in 2025, operating revenue will be 4.94B yuan, a year-on-year decrease of 14.55%. Net profit is 18.4951 million yuan, a year-on-year decrease of 13.85%. The profit distribution plan approved by the company’s board of directors is: based on 3B shares, a cash dividend of 0.10 yuan (tax included) will be distributed to all shareholders for every 10 shares.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin